14,061 Shares in Evolus, Inc. (NASDAQ:EOLS) Acquired by Intech Investment Management LLC

Intech Investment Management LLC bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 14,061 shares of the company’s stock, valued at approximately $228,000.

Several other institutional investors also recently bought and sold shares of the stock. Quest Partners LLC purchased a new stake in Evolus during the second quarter valued at $43,000. Quarry LP purchased a new stake in shares of Evolus during the 2nd quarter worth approximately $54,000. Profund Advisors LLC purchased a new position in Evolus in the second quarter worth about $130,000. Arizona State Retirement System raised its holdings in Evolus by 9.4% during the 2nd quarter. Arizona State Retirement System now owns 14,603 shares of the company’s stock valued at $158,000 after buying an additional 1,253 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its position in shares of Evolus by 65.0% during the third quarter. China Universal Asset Management Co. Ltd. now owns 12,135 shares of the company’s stock valued at $197,000 after buying an additional 4,780 shares during the period. 90.69% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have commented on EOLS. HC Wainwright reissued a “buy” rating and set a $27.00 target price on shares of Evolus in a research report on Thursday, November 7th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Evolus in a research report on Monday, September 16th. Barclays increased their price target on Evolus from $16.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday, September 13th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $22.00 price objective on shares of Evolus in a research note on Friday, September 13th.

Evolus Stock Down 2.1 %

NASDAQ:EOLS opened at $12.69 on Friday. The stock’s fifty day moving average is $15.03 and its two-hundred day moving average is $13.86. Evolus, Inc. has a 52 week low of $9.38 and a 52 week high of $17.82. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 20.58. The stock has a market capitalization of $803.53 million, a price-to-earnings ratio of -13.94 and a beta of 1.27.

Evolus Profile

Evolus, Inc, a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.